10 Jefferies Group AdaptHealth Trades
Jefferies Group's position in AdaptHealth is currently worth $44M. That's 0.75% of their equity portfolio (30th largest holding). The investor owns 3.43% of the outstanding AdaptHealth stock. The first AdaptHealth trade was made in Q4 2022. Since then Jefferies Group bought shares six more times and sold shares on three occasions. The investor's estimated purchase price is $48M, resulting in a loss of 8.3%.
Avg closing price
Price range
Increased shares by 21.4% (+842k shares)
Q2 2025
Avg closing price
$8.80
Price range
$7.33
-
$10.82
Increased shares by 294.1% (+2.94M shares)
Q1 2025
Avg closing price
$10.05
Price range
$8.45
-
$11.38
Sold 43.4% shares (-765k shares)
Q4 2024
Avg closing price
$10.13
Price range
$9.18
-
$11.00
Increased shares by 5329.1% (+1.73M shares)
Q3 2024
Avg closing price
$10.62
Price range
$8.66
-
$11.53
New holding (+32.5k shares)
Q2 2024
Avg closing price
$10.16
Price range
$9.19
-
$11.60
Sold -11.3k shares
Q4 2023
Avg closing price
$7.88
Price range
$6.49
-
$9.20
Increased shares by 2.2% (+240 shares)
Q3 2023
Avg closing price
$11.99
Price range
$8.60
-
$14.77
Sold 62.5% shares (-18.4k shares)
Q2 2023
Avg closing price
$11.14
Price range
$9.43
-
$12.52
Increased shares by 418.0% (+23.7k shares)
Q1 2023
Avg closing price
$18.40
Price range
$12.43
-
$22.73
New holding (+5.67k shares)
Q4 2022
Avg closing price
$21.14
Price range
$19.02
-
$23.00
News about AdaptHealth Corp and Jefferies Group
Jefferies Financial Group Downgrades AdaptHealth (NASDAQ:AHCO) to Hold
Jefferies Financial Group cut shares of AdaptHealth (NASDAQ:AHCO ¨C Free Report) from a buy rating to a hold rating in a research report released on Monday, M...